Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.1300 (-3.39%) ($5.1300 - $5.1300) on Mon. Mar. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.74% (three month average) | RSI | 28 | Latest Price | $5.1300(-3.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -13.6% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XLV(98%) XLK(82%) XME(67%) QQQ(59%) ONLN(58%) | Factors Impacting CAPR price | CAPR will decline at least -3.87% in a week (0% probabilities). OIH(-21%) UNG(-4%) VXX(-19%) PEJ(-24%) USO(-12%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.87% (StdDev 7.74%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-19.01(-470.57%) | Resistance Level | $6.6 | 5 Day Moving Average | $5.4(-5%) | 10 Day Moving Average | $5.78(-11.25%) | 20 Day Moving Average | $6.6(-22.27%) | To recent high | -35.4% | To recent low | 0.6% | Market Cap | $101m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |